Model
Edge
Kinnate BioPharma Inc.
KNTE
Filing Type
8-K
Filing Date
4/2/2024
Updated
4/3/24, 3:28 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Notice of Exempt Offering of Securities
EX-3.1
EX-3.1
EX-3.2
EX-3.2